Rapport Therapeutics (RAPP) Institutional Ownership $15.04 -1.33 (-8.12%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$15.22 +0.19 (+1.23%) As of 09/3/2025 06:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Rapport Therapeutics (NASDAQ:RAPP)Number ofInstitutional Buyers(last 12 months)46TotalInstitutional Inflows(last 12 months)$176.58MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$3.93M Get RAPP Insider Trade Alerts Want to know when executives and insiders are buying or selling Rapport Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data RAPP Institutional Buying and Selling by Quarter Rapport Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Bank of America Corp DE12,127$138K0.0%+62.5%0.033% 8/14/2025 Acuta Capital Partners LLC20,000$227K0.3%+22.0%0.055% 8/14/2025 Alliancebernstein L.P.1,154,688$13.13M0.0%+4.1%3.164% 8/14/2025 The Manufacturers Life Insurance Company 100,424$1.14M0.0%+27.2%0.275% 8/13/2025 Affinity Asset Advisors LLC199,643$2.27M0.3%N/A0.547% 8/13/2025 Kennedy Capital Management LLC11,230$128K0.0%N/A0.031% 8/12/2025 Rhumbline Advisers24,949$284K0.0%+73.8%0.068% 8/8/2025 Intech Investment Management LLC11,462$130K0.0%N/A0.031% 8/8/2025 Creative Planning10,602$121K0.0%N/A0.029% 8/8/2025 Geode Capital Management LLC333,159$3.79M0.0%+5.5%0.913% Get the Latest News and Ratings for RAPP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/28/2025 TD Asset Management Inc196,870$2.24M0.0%+20.9%0.539% 5/29/2025 Rhumbline Advisers14,358$144K0.0%+40.1%0.039% 5/23/2025 Siren L.L.C.378,469$3.80M0.2%-1.5%1.037% 5/19/2025 UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC203,242$2.04M0.0%N/A0.557% 5/16/2025 Goldman Sachs Group Inc.1,244,310$12.48M0.0%-0.6%3.409% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.9,887$99K0.0%+86.4%0.027% 5/15/2025 Siren L.L.C.378,469$3.80M0.2%-1.5%1.037% 5/14/2025 Corebridge Financial Inc.8,271$83K0.0%+79.1%0.023% 5/14/2025 MetLife Investment Management LLC10,863$109K0.0%+90.2%0.030% 5/14/2025 Jump Financial LLC13,760$138K0.0%N/A0.038% 5/14/2025 T. Rowe Price Investment Management Inc.1,551,925$15.57M0.0%-5.2%4.252% 5/12/2025 Nuveen LLC21,873$219K0.0%N/A0.060% 5/12/2025 Swiss National Bank31,900$320K0.0%+77.2%0.087% 5/9/2025 Deutsche Bank AG6,502$65K0.0%+180.6%0.018% 5/9/2025 Charles Schwab Investment Management Inc.90,968$912K0.0%+23.8%0.249% 5/8/2025 XTX Topco Ltd15,442$155K0.0%N/A0.042% 5/7/2025 TD Asset Management Inc162,818$1.63M0.0%-8.5%0.446% 4/30/2025 Alps Advisors Inc.26,128$262K0.0%-11.7%0.072% 4/29/2025 Bank of New York Mellon Corp35,482$356K0.0%+77.7%0.097% 4/8/2025 Rhumbline Advisers14,358$144K0.0%+40.1%0.039% 4/8/2025 Catalyst Private Wealth LLC10,000$100K0.0%N/A0.027% 4/7/2025 GAMMA Investing LLC9,208$918K0.0%+91,980.0%0.025% 3/18/2025 California State Teachers Retirement System8,571$152K0.0%+1,151.2%0.023% 2/17/2025 Woodline Partners LP181,530$3.22M0.0%-2.7%0.496% 2/17/2025 Deutsche Bank AG2,317$41K0.0%N/A0.006% 2/17/2025 Crestline Management LP27,496$488K0.0%N/A0.075% 2/17/2025 Bank of America Corp DE6,578$117K0.0%-65.6%0.018% 2/17/2025 Acuta Capital Partners LLC16,400$291K0.3%-6.8%0.045% 2/14/2025 Virtus ETF Advisers LLC3,740$66K0.0%N/A0.010% 2/14/2025 T. Rowe Price Investment Management Inc.1,636,931$29.04M0.0%-5.2%4.475% An $8 trillion-dollar discovery 17,000 ft underwater (Ad)A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.See the name and ticker behind America’s $16 trillion resource push.2/14/2025 Price T Rowe Associates Inc. MD1,143,384$20.29M0.0%+9.2%3.126% 2/14/2025 TRV GP V LLC7,135,233$126.58M43.1%N/A19.506% 2/14/2025 TRV GP VI LLC969,218$17.19M14.7%N/A2.650% 2/13/2025 Barclays PLC18,497$328K0.0%+43.8%0.051% 2/13/2025 Legal & General Group Plc9,523$169K0.0%+947.6%0.026% 2/13/2025 Wells Fargo & Company MN4,824$86K0.0%+38.9%0.013% 2/12/2025 Geode Capital Management LLC210,676$3.74M0.0%+4.4%0.576% 2/12/2025 Alliancebernstein L.P.1,098,415$19.49M0.0%+0.9%3.003% 2/12/2025 Norges Bank48,452$860K0.0%N/A0.132% 2/12/2025 JPMorgan Chase & Co.7,170$127K0.0%+77.8%0.020% 2/11/2025 KLP Kapitalforvaltning AS1,900$34K0.0%N/A0.005% 2/10/2025 Swiss National Bank18,000$319K0.0%N/A0.049% 1/31/2025 New York State Common Retirement Fund3,500$62K0.0%N/A0.010% 1/30/2025 Rhumbline Advisers10,249$182K0.0%-35.3%0.028% 1/24/2025 Jennison Associates LLC62,287$1.11M0.0%N/A0.170% 1/24/2025 China Universal Asset Management Co. Ltd.7,756$138K0.0%N/A0.021% 12/26/2024 JPMorgan Chase & Co.4,033$83K0.0%N/A0.011% 11/19/2024 Barclays PLC12,863$264K0.0%+36.8%0.035% 11/16/2024 Geode Capital Management LLC201,748$4.13M0.0%N/A0.552% 11/15/2024 Barclays PLC12,863$264K0.0%+36.8%0.035% 11/15/2024 State Street Corp58,046$1.19M0.0%N/A0.159% 11/15/2024 Maven Securities LTD29,930$613K0.0%N/A0.082% 11/14/2024 Eventide Asset Management LLC110,401$2.26M0.0%+120.8%0.302% 11/14/2024 Acuta Capital Partners LLC17,600$360K0.3%-12.0%0.048% 11/14/2024 MetLife Investment Management LLC5,710$117K0.0%N/A0.016% 11/13/2024 BNP Paribas Financial Markets1,684$34K0.0%N/A0.005% 11/13/2024 FMR LLC5,486,468$112.36M0.0%+10.1%14.999% 11/13/2024 The Manufacturers Life Insurance Company77,344$1.58M0.0%+2.4%0.211% 11/12/2024 Charles Schwab Investment Management Inc.73,146$1.50M0.0%N/A0.200% 11/7/2024 LMR Partners LLP20,000$410K0.0%-60.0%0.055% 10/23/2024 Values First Advisors Inc.1,507$31K0.0%N/A0.004% 10/3/2024 SG Americas Securities LLC4,934$101K0.0%N/A0.014% 8/27/2024 Logos Global Management LP208,910$4.86M0.4%N/A0.591% 8/16/2024 Perceptive Advisors LLC748,183$17.40M0.4%N/A2.045% 8/15/2024 The Manufacturers Life Insurance Company75,516$1.76M0.0%N/A0.206% 8/15/2024 Millennium Management LLC116,782$2.72M0.0%N/A0.319% 8/14/2024 Squarepoint Ops LLC16,345$380K0.0%N/A0.045% 8/14/2024 Sandia Investment Management LP5,000$116K0.2%N/A0.014% 8/14/2024 ARCH Venture Management LLC3,728,738$86.73M31.6%N/A10.193% 8/14/2024 Davidson Kempner Capital Management LP10,000$229K0.0%N/A0.027% 8/10/2024 Sofinnova Investments Inc.1,951,562$45.39M2.4%N/A5.516% 8/9/2024 Johnson & Johnson2,498,051$58.11M14.5%N/A7.061% 8/3/2024 TD Asset Management Inc101,522$2.36M0.0%N/A0.287% (Data available from 1/1/2016 forward) RAPP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RAPP shares? During the previous two years, 61 institutional investors and hedge funds held shares of Rapport Therapeutics. The most heavily invested institutionals were TRV GP V LLC ($126.58M), FMR LLC ($112.36M), ARCH Venture Management LLC ($86.73M), Johnson & Johnson ($58.11M), Sofinnova Investments Inc. ($45.39M), Price T Rowe Associates Inc. MD ($20.29M), and Perceptive Advisors LLC ($17.40M).Learn more on Rapport Therapeutics' institutional investors. Which institutional investors have been buying Rapport Therapeutics' stock? Of the 55 institutional investors that purchased Rapport Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: TRV GP V LLC ($7.14M), ARCH Venture Management LLC ($3.73M), Johnson & Johnson ($2.50M), Sofinnova Investments Inc. ($1.95M), TRV GP VI LLC ($969.22K), Perceptive Advisors LLC ($748.18K), and FMR LLC ($503.12K). How much institutional buying is happening at Rapport Therapeutics? Institutional investors have bought a total of 10,090,007 shares in the last 24 months. This purchase volume represents approximately $176.58M in transactions. Which of Rapport Therapeutics' major shareholders have been selling company stock? Of the 10 institutional investors that sold Rapport Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: T. Rowe Price Investment Management Inc. ($175.19K), LMR Partners LLP ($30K), TD Asset Management Inc ($15.09K), Bank of America Corp DE ($12.53K), Siren L.L.C. ($11.46K), Goldman Sachs Group Inc. ($7.83K), and Rhumbline Advisers ($5.59K). How much institutional selling is happening at Rapport Therapeutics? Institutional investors have sold a total of 269,764 shares in the last 24 months. This volume of shares sold represents approximately $3.93M in transactions. Related Companies RXRX Institutional Ownership OCUL Institutional Ownership IRON Institutional Ownership CGON Institutional Ownership BLTE Institutional Ownership MESO Institutional Ownership ADPT Institutional Ownership SRPT Institutional Ownership ANIP Institutional Ownership ARQT Institutional Ownership This page (NASDAQ:RAPP) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapport Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapport Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RAPP Stock Alerts